Military Medical Research Leads to 18 New Cancer Drugs, Other Devices

Home / Articles / External Government

Michelle Pribble, Naval Medical Center San Diego's lead nuclear medicine technologist, prepares a patient for a positron emission tomography (PET) scan in the hospital's Nuclear Medicine Department on October 6. A PET scan is used for revealing or evaluating conditions, including brain disorders (photo by Navy Mass Communication Specialist Seaman Luke Cunningham).
Michelle Pribble, Naval Medical Center San Diego's lead nuclear medicine technologist, prepares a patient for a positron emission tomography (PET) scan in the hospital's Nuclear Medicine Department on October 6. A PET scan is used for revealing or evaluating conditions, including brain disorders (photo by Navy Mass Communication Specialist Seaman Luke Cunningham).

July 20, 2021 | Originally published by Military Health System on July 14, 2021

In just the past year, they’ve been working on new, high-tech treatments for major health problems like cancer, severe hearing loss, and genetic diseases like muscular dystrophy.

While the Congressionally Directed Medical Research Programs, known as CDMRP, is not really a household name that is immediately familiar to many people in the military community, it is well known among medical researchers around the world.

The CDMRP is essentially a U.S. Department of Defense funding organization that has been a hub of cutting-edge healthcare innovation financing since the early 1990s and has impacted health care development inside and outside the military for decades.

Focus Areas

Want to find out more about this topic?

Request a FREE Technical Inquiry!